Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Re ...

10x Genomics, Inc. (NASDAQ:TXG) Q2 2020 Results Conference Call August 11, 2020 4:30 PM ET Company Participants Eric Jaschke - Director of Investor Relations and Strategic Finance Serge Saxonov - Co-Founder & Chief Executive Officer Justin McAnear - Chief Financial Officer Bradford Crutchfield - Chief Commercial Officer Conference Call Participants Tycho Peterson - JP Morgan Derik De Bruin - Bank of America Doug Schenkel - Cowen Luke Sergott - Evercore ISI Patrick Donnelly - Citigroup Daniel Arias - Stife ...

10x Genomics, Inc. (NASDAQ:TXG) Q1 2020 Results Conference Call May 11, 2020 4:30 PM ET Company Participants Carrie Mendivil - Investor Relations Serge Saxonov - Co-Founder & Chief Executive Officer Justin McAnear - Chief Financial Officer Brad Crutchfield - Chief Commercial Officer Conference Call Participants Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Doug Schenkel - Cowen Patrick Donnelly - Citi David Westenberg - Guggenheim Securities Operator Ladies and gentlemen, thank you for standing ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 45-5614458 (State or other jurisdiction of incorporation or organization) 6230 Stoneridge Mall Road Pleasanton, Ca ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 45-5614458 | | | --- ...

10x Genomics, Inc. (NASDAQ:TXG) Q4 2019 Earnings Conference Call February 18, 2020 4:30 PM ET Company Participants Serge Saxonov - Co-Founder & Chief Executive Officer Justin McAnear - Chief Financial Officer Brad Crutchfield - Chief Commercial Officer Conference Call Participants Mike Ryskin - Bank of America Adam Wieschhaus - Cowen Luke Sergott - Evercore Patrick Donnelly - Citi Operator Ladies and gentlemen, thank you for standing by and welcome to the 10x Genomics Fourth Quarter Earnings Conference. At ...

Mastering Biology to Advance Human Health Serge Saxonov CEO, Co-Founder Safe Harbor Statement Certain statements in this presentation and the accompanying oral commentary are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements, other than statements of historical facts may be forward-looking statements. Thes ...

Table of Contents ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended September 30, 2019 Washington, D.C. 20549 OR FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. Indicate by check mark whether the registrant has submitted electronically every ...

10x Genomics Inc. (NASDAQ:TXG) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Serge Saxonov - Founder & CEO Justin McAnear - CFO Brad Crutchfield - Chief Commercial Officer Conference Call Participants Tycho Peterson - JPMorgan Adam Wieschhaus - Cowen & Company Luke Sergott - Evercore ISI Operator Good afternoon, ladies and gentlemen, and welcome to the 10x Genomics Q3 2019 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to yo ...